par El Saghir, Nagi S;Tfayli, Arafat;Hatoum, Hassan A;Nachef, Zahi;Dinh, Phuong 
;Awada, Ahmad
Référence Critical reviews in oncology/hematology, 80, 3, page (433-449)
Publication Publié, 2011-12
;Awada, Ahmad Référence Critical reviews in oncology/hematology, 80, 3, page (433-449)
Publication Publié, 2011-12
Article révisé par les pairs
| Titre: |
|
| Auteur: | El Saghir, Nagi S; Tfayli, Arafat; Hatoum, Hassan A; Nachef, Zahi; Dinh, Phuong; Awada, Ahmad |
| Informations sur la publication: | Critical reviews in oncology/hematology, 80, 3, page (433-449) |
| Statut de publication: | Publié, 2011-12 |
| Sujet CREF: | Cancérologie |
| Mots-clés: | Anthracyclines |
| Anti-angiogenesis | |
| Anti-EGFR | |
| Anti-ErbB2 targeted therapy | |
| Anti-RANKL | |
| Aromatase inhibitors | |
| Bisphosphonates | |
| Chemotherapy | |
| Endocrine treatment | |
| Metastatic breast cancer | |
| Palliation | |
| PARP inhibitors | |
| Survival | |
| Taxanes | |
| MeSH keywords: | Angiogenesis Inhibitors -- therapeutic use |
| Antineoplastic Agents, Hormonal -- therapeutic use | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Breast Neoplasms -- classification -- secondary -- therapy | |
| Female | |
| Humans | |
| Molecular Targeted Therapy | |
| Palliative Care | |
| Poly(ADP-ribose) Polymerases -- antagonists & inhibitors | |
| Prognosis | |
| RANK Ligand -- antagonists & inhibitors | |
| Receptor, Epidermal Growth Factor -- antagonists & inhibitors | |
| Receptor, erbB-2 -- metabolism | |
| Recurrence | |
| Note générale: | Journal Article |
| Review | |
| SCOPUS: re.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1040-8428 |
| info:doi/10.1016/j.critrevonc.2011.01.010 | |
| info:pii/S1040-8428(11)00021-7 | |
| info:scp/80655127884 | |
| info:pmid/21330148 |
